Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.285 USD | -1.49% | -9.94% | -29.38% |
05-10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
05-07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.38% | 5.43M | |
+33.37% | 49.46B | |
+1.75% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.58% | 26.61B | |
-21.80% | 18.64B | |
+7.87% | 13.16B | |
+29.73% | 12.55B | |
+23.58% | 12.1B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise